EX-FILING FEES 5 fs12022ex-fee_helixacquis.htm FILING FEE TABLE

Exhibit 107

 

EX-FILING FEES

 

Calculation of Filing Fee Tables

 

Form S-1
(Form Type)

 

Helix Acquisition Corp.
(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

Table 1—Newly Registered and Carry Forward Securities  
    Security Type   Security Class Title (1)   Fee Calculation or Carry Forward Rule     Amount Registered (2)     Proposed Maximum Offering Price Per Unit (3)     Maximum Aggregate Offering Price (3)     Fee Rate     Amount of Registration Fee     Carry Forward Form Type     Carry Forward File Number     Carry Forward Initial effective date     Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward  
Newly Registered Securities  
Fees to Be Paid   Equity(1)   Class A ordinary shares, $0.0001 par value per share     457(c)       11,500,000 shares      $ 9.89      $ 113,723,500.00     0.0000927     10,542.17                          
Fees Previously Paid                                               —        —        —        —   
Carry Forward Securities  
Carry Forward Securities                                                                      
    Total Offering Amounts             $ 113,723,500.00             $ 10,542.17                                  
    Total Fees Previously Paid                             $ 0                                  
    Total Fee Offsets                             $ 0                                  
    Net Fee Due                             $ 10,542.17                                  

 

(1)These securities are being registered solely in connection with the resale of the registrant’s Class A ordinary shares by certain selling shareholders (the “Selling Shareholders”) named in this registration statement. The Selling Shareholders have committed to purchase up to 11,500,000 Class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), of Helix Acquisition Corp. (“Helix”) immediately prior to the consummation of its business combination with MoonLake Immunotherapeutics AG.
(2)Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting of any share dividend, sub-division, recapitalization or other similar transactions.
(3)Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, based on the average of the high and low prices of the Class A Ordinary Shares as reported on February 3, 2022, which was $9.89 per share.